Cas:13720-94-0 Ethyl 4-chloro-3-quinolinecarboxylate manufacturer & supplier

Chemical Name:Ethyl 4-chloro-3-quinolinecarboxylate

CAS.NO:13720-94-0

Synonyms:Ethyl 4-chloro-3-quinolinecarboxylate;MFCD00173407;ethyl 4-chloroquinoline-3-carboxylate;4-Chloroquinoline-3-carboxylic acid ethyl ester;3-Quinolinecarboxylic acid, 4-chloro-, ethyl ester

Molecular Formula:C₁₂H₁₀ClNO₂

Molecular Weight:235.666

HS Code:2933499090

Physical and Chemical Properties:

Melting point:46-48°C

Boiling point:328.5±22.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.610

PSA:39.19000

Exact Mass:235.040009

LogP:3.13

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 4-chloro-3-quinolinecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Quinolinecarboxylic acid, 4-chloro-, ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Quinolinecarboxylic acid, 4-chloro-, ethyl ester Use and application,MFCD00173407 technical grade,usp/ep/jp grade.

Related News: Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. Ethyl 4-chloro-3-quinolinecarboxylate manufacturer Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma. Ethyl 4-chloro-3-quinolinecarboxylate supplier Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma. Ethyl 4-chloro-3-quinolinecarboxylate vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. Ethyl 4-chloro-3-quinolinecarboxylate factory Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves.